Recent Articles from GlobeNewswire

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Apogee (NASDAQ: APGE) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with CRH.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Bio-Techne (NASDAQ: TECH) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Merck.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against Gildan (NYSE and TSX: GIL). The investigation results from inaccurate statements Gildan may have made regarding its financial statements, business operations and prospects.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) --

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against GPGI (NYSE: GPGI). The investigation results from inaccurate statements GPGI may have made regarding its financial statements, business operations and prospects.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Arcosa (NYSE: ACA) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with CRH.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating AstroNova (NASDAQ: ALOT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Arcline.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Huntsman (NYSE: HUN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Olin.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Fathom (NASDAQ: FTHM) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Bed Bath & Beyond.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Simulations Plus (NASDAQ: SLP) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Altaris.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Nuvalent (NASDAQ: NUVL) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with GSK plc.

Strongest earthquake to impact Venezuela since 1900 causes widespread damage across northern Venezuela and highlights challenges within the country's insurance market

BOCA RATON, Fla., July 02, 2026 (GLOBE NEWSWIRE) --  Americans may be paying less at the gas pump than they were a month ago, but that relief isn’t showing up in the traditional Fourth of July food spread.

BEIJING, July 02, 2026 (GLOBE NEWSWIRE) -- iQIYI, Inc. (Nasdaq: IQ) (“iQIYI” or the “Company”), a leading provider of online entertainment video services in China, today announced the appointment of Mr. Ying Tian as Chief Financial Officer of the Company, effective today. Concurrently, Ms. Ying Zeng will step down from her position as Interim Chief Financial Officer and resume the role of Senior Vice President of Finance.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Payoneer (NASDAQ: PAYO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Nuvei.

SYDNEY, July 02, 2026 (GLOBE NEWSWIRE) -- Stellar Resources Limited (ASX: SRZ) is pleased to announce a significant update to the Mineral Resource Estimate (MRE) at its flagship Heemskirk Tin Project in the tier-1 mining jurisdiction of Western Tasmania. The updated MRE features a 64% increase in the Total Mineral Resource at the Severn deposit, reaching 8.54Mt at 0.82% Sn for 70,002 tonnes of contained tin.

MILWAUKEE, July 02, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Roku (NASDAQ: ROKU) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Fox.

First selective MET inhibitor approved for patients with MET-amplified advanced gastric cancer or gastroesophageal junction adenocarcinoma in China

ZUG, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic and ophthalmic diseases with significant unmet medical needs, announced today that Oculis’ management will participate in a fireside chat at the Piper Sandler Virtual Ophthalmology Conference.

BASEL, Switzerland, July 02, 2026 (GLOBE NEWSWIRE) --  Anaveon, a late-stage biotechnology company pioneering precision biologics to reprogram the immune system for the treatment of autoimmune and inflammatory diseases, today announced the appointment of Laetitia Pouzol, PharmD, Ph.D., as Chief Scientific Officer. This internal promotion recognizes Laetitia’s outstanding contributions since joining the company in March 2025 as Head of Immunology, where she has been instrumental in advancing the company’s immunology programs.

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Transaction expands Symbotic’s solution from automation execution to full-scale, AI-powered operational intelligence across the entire warehouse ecosystem

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $920M (€807M)

SINGAPORE, July 02, 2026 (GLOBE NEWSWIRE) -- Qoder, the agentic coding platform, today introduced off-peak pricing for Qwen3.7-Max and Qwen3.7-Plus, the latest models in Qwen family. During off-peak hours, defined as 14:00 to 00:00 UTC daily, both models are billed at reduced Credits multipliers. During regular hours (00:00 to 14:00 UTC), Qwen3.7-Max is billed at a 0.25x Credits multiplier, half its standard 0.5x rate. The discount is applied automatically for all Pro Trial and paid users, with no opt-in or signup, and works across every Qoder product. Together, the two windows make Qoder the most cost-effective way to build with Qwen3.7-Max and Qwen3.7-Plus.

ISS, a leading global workplace experience and facility services company, has extended and expanded its partnership with a public healthcare provider in Southern Europe. The expanded scope of the agreement has an annual value of approximately DKK 100 million.

LexisNexis Risk Solutions’ risk intelligence with Promon Shield in-app protection and Promon Insight trusted telemetry together aim to help organizations protect mobile apps from manipulation and enable more trusted fraud decisions

Issy-les-Moulineaux, July 2, 2026 (7:00 a.m. CEST)Sodexo (Euronext Paris FR 0000121220-OTC: SDXAY)

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass. and VILLEJUIF, France, July 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners”), and Orano Med, a clinical-stage radiopharmaceutical company and a pioneer in the development of lead-212 (212Pb) based targeted alpha therapies (TAT), today announced that the first patients were dosed in the ongoing US multicenter Phase 1/2a study of drug candidate MP0712.

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX) (“Elicio” or the “Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that it has entered into a definitive securities purchase agreement led by two new fundamental institutional investors with participation from a large existing shareholder for the purchase of an aggregate of 4,380,313 shares of its common stock pursuant to a registered direct offering (the “Offering”). The Offering is expected to result in gross proceeds of approximately $15 million, before deducting placement agents’ fees and other Offering expenses. The closing of the Offering is expected to occur on or about July 6, 2026, subject to the satisfaction of customary closing conditions. Elicio intends to use the net proceeds from the Offering, together with its existing cash, cash equivalents and marketable securities, to primarily fund the planned Phase 1 clinical development of ELI-002 7P in metastatic PDAC and Elicio’s pipeline and platform, as well as for working capital and general corporate purposes.

Latest assays such as 42m @ 6.1% CuEq and 9.8m @ 16.5% CuEq, which demonstrate the outstanding continuity of the high-grade zone, will feed into the impending economic studies

MELBOURNE, Australia and INDIANAPOLIS, July 02, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX, “Telix”) today announced the successful outcome of a Type B meeting with the United States (U.S.) Food and Drug Administration (FDA) to review the Part 1 safety and dosimetry data and Part 2 protocol design of the ProstACT Global Phase 3 trial of its therapeutic candidate TLX591-Tx (lutetium-177 (177Lu) rosopatamab tetraxetan) in metastatic castration resistant prostate cancer.

Japan-Originated Global Biopharma Company Founded in 2001 Enters Its “Second Founding Phase”

Marsha Reyngold, M.D., Ph.D. v. National Institutes of Health, National Library of Medicine, Department of Health and Human Services

SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the company has recently entered into a license agreement with Fosun Wanbang Pharma Group (“Fosun Wanbang,” a wholly-owned subsidiary of Fosun Pharma (HKEX: 02196; SSE: 600196). The two parties will cooperate on the development, registration, manufacturing and commercialization of roconkibart (JS005, anti-IL-17A monoclonal antibody) in the Greater China region, which includes the Chinese mainland, Hong Kong Special Administrative Region, Macao Special Administrative Region, and Taiwan.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Badger Meter, Inc. (“Badger Meter” or the “Company”) (NYSE:BMI) investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.

State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Meridian3 Industrials Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 17,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market, or Nasdaq, and trade under the ticker symbol “MIACU” with trading expected to begin on July 2, 2026. Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share, subject to certain adjustments. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “MIAC” and “MIACW,” respectively.

Sworn Declarations from Former FDA Counsel and Renowned Device Regulation Expert Expose Clear Regulatory Carve-Outs for Outpatient Clinics; Emergency Motion Seeks to Strike Verdict Before July 7 Sentencing

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) --

PASADENA, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Wedbush today announced that Dan Ives, MD, Global Head of Technology Research, has departed the firm to establish a new investment banking venture.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Guggenheim Investments today announced that certain closed-end funds have declared their distributions. The table below summarizes the distribution schedule for each closed-end fund (collectively, the “Funds” and each, a “Fund”).

Recognition validates technical expertise in mission-critical environments and enables the company to deploy solutions built on Google's most advanced models

TORONTO, July 01, 2026 (GLOBE NEWSWIRE) -- Abaxx Technologies Inc. (TSX:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that Abaxx Exchange surpassed 100,000 contracts traded in a single day on July 1, 2026, with total volume reaching 117,879 contracts.

Amendment Modernizes Commercial Terms, Lowers Future Subscriber Costs, and Strengthens the Company’s Balance Sheet

BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Following its highly anticipated opening, The Atlas Hotel unveils the details of its highly curated art and design program. Developed by global real estate leader Tishman Speyer at the gateway of Harvard University’s Enterprise Research Campus, The Atlas’ art initiative goes beyond the city’s traditional hotel model. With its art program, The Atlas presents a collection of contemporary and emerging artists whose works are exhibited across premier galleries and art museums in New York, Boston, Los Angeles, and beyond.

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Phreesia (PHR) To Contact Them Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Melissa Fortunato Encourage Investors Who Suffered Losses In Black Rock (BRCB) To Contact Them Directly To Discuss Their Options

RENO, Nev., July 01, 2026 (GLOBE NEWSWIRE) -- Employers Holdings, Inc. (NYSE:EIG), today announced that on June 25, 2026, Stephanie C. Bush was elected to the Board of Directors, with her term of service commencing on July 1, 2026.

HAMILTON, Bermuda, July 01, 2026 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty underwriter, has today announced the appointment of Mark Aspinall as Head of its new Fine Art & Specie team, effective January 2027.

FRISCO, TX, July 01, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its second quarter 2026 results on July 29, 2026 after the market closes and host its quarterly conference call at 10:00 a.m. CT on July 30, 2026 to discuss the second quarter results.  

CALHOUN, Ga., July 01, 2026 (GLOBE NEWSWIRE) -- In conjunction with Mohawk Industries’ (NYSE: MHK) Second Quarter 2026 earnings release on Thursday, July 30, 2026, you are invited to listen to the conference call that will be broadcast live on Friday, July 31, 2026, at 11:00 am ET.

HOUSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) will announce its second quarter 2026 financial results after close of market on Wednesday, August 5, 2026, and will hold a conference call to discuss the results on Thursday, August 6, 2026, at 1 p.m. Eastern/12 p.m. Central.

If you purchased or acquired FS KKR Capital securities between May 8, 2024 and February 25, 2026 and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone at (212) 355-4648.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Sportradar (SRAD) To Contact Him Directly To Discuss Their Options

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- National Healthcare Properties, Inc. (Nasdaq: NHP / NHPAP / NHPBP) (the “Company”) announced today that its Board of Directors declared a quarterly dividend of $0.075 per share of its common stock (including its Class A Common Stock). The dividend will be payable in cash on July 30, 2026 to holders of record at the close of business on July 15, 2026.

SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) --  Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that management will participate in the following investor conferences in the third quarter of 2026.

Batesville, Ark., July 01, 2026 (GLOBE NEWSWIRE) -- FutureFuel Corp. (NYSE: FF) (“FutureFuel”), a leading manufacturer of specialty chemicals and renewable biofuels, announced that it has finalized the sale of all its 2025 Section 45Z Clean Fuel Production and Small Producer Tax Credits to Freepoint Commodities (“Freepoint”). The credits stem from low-carbon biodiesel produced at the company’s Batesville facility.

LONDON & GAITHERSBURG, Md., July 01, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced that the Compensation Committee of the Company's Board of Directors granted stock option awards to purchase an aggregate of 25,420 American Depositary Shares and 87,530 restricted stock units (RSUs), each representing an equal number of ordinary shares, to 13 employees pursuant to the Company’s 2025 Inducement Plan. The stock options and RSUs were granted as an inducement material to the individual becoming an employee of Autolus in accordance with Nasdaq Listing Rule 5635(c)(4).

NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve disease outcomes for patients with cancer, today announced that on June 30, 2026, the Compensation Committee of Candel’s Board of Directors (the Board) granted to one new employee, stock options to purchase an aggregate of 25,000 shares of the Company’s common stock, with a per share exercise price of $10.30.

SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI), the leading provider of a unified real-time intelligence platform for casino resorts, today announced its participation in Raving's Casino Marketing & Technology Conference (CMTC) and Host & Player Development Conference, taking place July 14–16 at Pechanga Resort Casino in Temecula, California.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on July 1, 2026, the Company granted inducement awards to purchase up to 250,700 shares of common stock to eight new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

Sixty-four consecutive quarters of increased quarterly cash dividend on its common stock

Company fully subscribed its inaugural Regulation A+ offering at the $25.7 million ceiling—nearly double the program average—requalified with the SEC and now reopens at an increased share price amid surging investor demand for energy technology

PASCAGOULA, Miss., July 01, 2026 (GLOBE NEWSWIRE) -- HII’s (NYSE: HII) Ingalls Shipbuilding division began fabrication of the future USS John F. Lehman (DDG 137) Monday, marking the official start of construction on the Navy’s newest Flight III Arleigh Burke‑class destroyer.

2,500 oz America 250 Silver Coin Certified During Official Ceremony in Austin, Texas

Long Beach, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Long Beach City College (LBCC) Athletics announced today a strategic reinvestment plan for the college’s baseball program tied to the future construction and modernization of the campus baseball complex. The area immediately south of Lew Davis Street is entering a period of significant transformation affecting multiple college operations, including student housing, baseball facilities, and future stadium and athletics complex renovations. These changes are part of a long-term investment strategy designed to modernize campus facilities and strengthen the future of LBCC Athletics, including the eventual return of baseball in a renewed and enhanced environment. 

The Ph.D. program will highlight the interdisciplinary nature of the rapidly evolving field of cybersecurity, with artificial intelligence and other emerging technologies.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- D S Simon Media, a recognized innovator in broadcast public relations and AI search optimization, is celebrating its 40th anniversary on July 4th. "Obviously, a lot has changed during those 40 years, but what has stayed the same is the importance of discoverability for organizations and our ability to help them be found,” says founder and CEO Doug Simon.

NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- The American Kennel Club (AKC®), a not-for-profit organization that is the world’s largest registry of purebred and mixed-breed dogs, and a leading voice for canine welfare and responsible ownership, reminds dog owners the importance of keeping you and your pup cool in this heat.